A COVID-19 vaccine might be ready within 18 months. But what happens then?
Developing and manufacturing a vaccine against COVID-19 is only part of the solution. Coordination, political will, and the infrastructure to support equitable vaccine is distribution will be essential to the ongoing COVID-19 response.
Potential plasma treatments for COVID-19: A conversation with Dr. Toni Hoover
Dr. Toni Hoover, director of Strategy, Planning, and Management for Global Health at the Gates Foundation, shares what the CoVig Alliance means for the wider fight against COVID-19—and the foundation's role.
Sign up for The Optimist newsletter
Subscribe to The Optimist to get weekly updates on the latest in global health, gender equality, education, and more.